Investment Criteria

  • It has to be Agetech

    We define Agetech broadly: if it helps older adults, their caregivers, or any of the systems supporting them, it’s Agetech. Healthcare related? Since people age 55 and over account for over half of total healthcare spending, it’s probably Agetech. Tools that enable Agetech entrepreneurs? It’s Agetech. Things for kids or pregnancy? Probably not Agetech. If you’re not sure, reach out and ask!

  • 12+ Months of Runway

    Entrepreneurship is full of unexpected twists and turns. At the time our check hits your account, you need to have at least 12 months of breathing room to build, learn, and grow. If you’re just trying to eke out a few extra months to increase the next round’s valuation, good luck to you, it’s not for us.

  • No FDA Risk

    We don’t invest in pharma or biotech. Getting FDA approval is make-or-break for many startups and can be wildly profitable, but it’s not a risk we’re willing to take. Fortunately there are lots of other VCs out there who do, go get em! Also, if you’re looking to speed up the FDA approval process check out our portfolio company neMedIO, that’s their specialty.

  • Global

    We’ve already made investments in the US, Canada, Japan, and the UK. We’ve also looked at many opportunities throughout Western Europe and Israel. Aging is global, as is the Agetech opportunity, so we’re constantly looking at new markets to invest in.

Have we invested in a competitor? Don’t worry!

It actually makes us more likely to invest in you, we’re already convinced of the opportunity!

Most VCs take board seats, we don’t. Most VCs make only one investment per sector, we don’t. We invest early, and since there’s so much green space, it’s incredibly rare for Agetech startups to butt heads until years after our investment. We have yet to find a “winner takes all” Agetech sector, so we have no problem investing in multiple winners!